Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

Summary

This is a single site study to determine the structural efficacy of sarilumab when administered to biologic naive patients with active rheumatoid arthritis

Timeline

Start

2018-06-01

Primary completion

2020-12-30

Completion

2020-12-30

Drugs

Indications